Appistry, Inc., a provider of software and services that enable healthcare institutions to practice genomically enhanced medicine, has announced the availability of GenomePilot in the Microsoft Azure Marketplace. Through a new collaboration, Appistry will actively participate with Microsoft and other partners in the development of a complete set of cloud-based services for research and clinical genomics.
"We are excited that Appistry's GenomePilot is now available in the Azure Marketplace," said Nicole Herskowitz, Senior Director of Product Marketing for Microsoft Azure. "GenomePilot on Azure will help healthcare organizations make optimal use of data to diagnose disease, develop precision treatments, and understand the causes of genetic disorders ranging from inherited cancers to rare and complex childhood conditions."
To learn more about GenomePilot and its sophisticated services, read the press release.